Zhangzhou Pientzehuang Pharmaceutical Co Ltd Asset Resilience Ratio
Zhangzhou Pientzehuang Pharmaceutical Co Ltd asset resilience ratio. Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has an Asset Resilience Ratio of 17.40% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Zhangzhou Pientzehuang Pharmaceutical Co (600436) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2003–2024)
Asset resilience ratio of Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2003 to 2024. This chart shows how Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read Zhangzhou Pientzehuang Pharmaceutical Co (600436) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Zhangzhou Pientzehuang Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Zhangzhou Pientzehuang Pharmaceutical Co (600436) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥3.26 Billion | 17.4% |
| Total Liquid Assets | CN¥3.26 Billion | 17.40% |
Asset Resilience Insights
- Good Liquidity Position: Zhangzhou Pientzehuang Pharmaceutical Co Ltd maintains a healthy 17.40% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhangzhou Pientzehuang Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Novartis AG
SW:NOVN |
Drug Manufacturers - General | 0.08% |
|
AstraZeneca PLC
NASDAQ:AZN |
Drug Manufacturers - General | 0.10% |
|
Pfizer Inc
SA:PFIZ34 |
Drug Manufacturers - General | 5.33% |
|
Novartis AG
MX:NVSN |
Drug Manufacturers - General | 0.08% |
|
Biogen Inc
NASDAQ:BIIB |
Drug Manufacturers - General | 0.00% |
|
Organon & Co
NYSE:OGN |
Drug Manufacturers - General | 4.46% |
|
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019 |
Drug Manufacturers - General | 0.53% |
|
GuangYuYuan Chinese Herbal Medicine Co Ltd
SHG:600771 |
Drug Manufacturers - General | 1.97% |
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2003–2024)
Zhangzhou Pientzehuang Pharmaceutical Co Ltd asset resilience ratio by year from 2003 to 2024. The table below shows the annual Asset Resilience Ratio data for Zhangzhou Pientzehuang Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 20.07% | CN¥3.52 Billion ≈ $515.03 Million |
CN¥17.54 Billion ≈ $2.57 Billion |
-33.14pp |
| 2023-12-31 | 53.21% | CN¥9.09 Billion ≈ $1.33 Billion |
CN¥17.08 Billion ≈ $2.50 Billion |
+53.14pp |
| 2021-12-31 | 0.07% | CN¥8.80 Million ≈ $1.29 Million |
CN¥12.50 Billion ≈ $1.83 Billion |
+0.07pp |
| 2020-12-31 | 0.00% | CN¥13.37K ≈ $1.96K |
CN¥10.21 Billion ≈ $1.49 Billion |
0.00pp |
| 2019-12-31 | 0.00% | CN¥19.22K ≈ $2.81K |
CN¥8.81 Billion ≈ $1.29 Billion |
0.00pp |
| 2018-12-31 | 0.00% | CN¥46.84K ≈ $6.85K |
CN¥6.66 Billion ≈ $974.24 Million |
+0.00pp |
| 2017-12-31 | 0.00% | CN¥24.29K ≈ $3.55K |
CN¥5.65 Billion ≈ $826.52 Million |
0.00pp |
| 2016-12-31 | 0.00% | CN¥134.97K ≈ $19.75K |
CN¥5.04 Billion ≈ $737.19 Million |
+0.00pp |
| 2013-12-31 | 0.00% | CN¥42.56K ≈ $6.23K |
CN¥3.26 Billion ≈ $476.94 Million |
+0.00pp |
| 2011-12-31 | 0.00% | CN¥838.64 ≈ $122.72 |
CN¥1.57 Billion ≈ $229.55 Million |
-0.01pp |
| 2010-12-31 | 0.01% | CN¥94.31K ≈ $13.80K |
CN¥1.45 Billion ≈ $211.72 Million |
-0.39pp |
| 2009-12-31 | 0.39% | CN¥5.05 Million ≈ $738.37K |
CN¥1.28 Billion ≈ $187.97 Million |
+0.05pp |
| 2006-12-31 | 0.34% | CN¥2.49 Million ≈ $364.22K |
CN¥730.62 Million ≈ $106.91 Million |
-0.74pp |
| 2005-12-31 | 1.09% | CN¥7.53 Million ≈ $1.10 Million |
CN¥693.63 Million ≈ $101.50 Million |
-1.93pp |
| 2004-12-31 | 3.01% | CN¥16.83 Million ≈ $2.46 Million |
CN¥558.77 Million ≈ $81.77 Million |
-18.31pp |
| 2003-12-31 | 21.32% | CN¥126.88 Million ≈ $18.57 Million |
CN¥594.99 Million ≈ $87.07 Million |
-- |
About Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and distributes pharmaceuticals and cosmetics in China and internationally. The company offers traditional Chinese medicines and health products in various forms, including capsule, ointment, tablet, syrup, and pill; health care food and functional drinks; special efficacy cosmetics; and household chemic… Read more